Joshua Z Drago

8PUBLICATIONS
29CO-AUTHORS
Clinical midwiferyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 10, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.

Wanyi Chen, Avantika Gupta, Nicholas Mai

|Nov 06, 2024
Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?

Joshua Drago, Shanu Modi

|Apr 03, 2023
ADCs or: How I Learned to Stop Worrying and Love Chemotherapy.

Avantika Gupta, Joshua Z Drago, Sarat Chandarlapaty

|Oct 20, 2021
Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.

Christopher J Schwartz, Edaise M da Silva, Antonio Marra

|May 05, 2021
A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer.

Komal Jhaveri, Joshua Z Drago, Payal Deepak Shah

Pageof 2